相关实验视频

Updated: Jun 17, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.4K

杜尔瓦卢马布诱导的三重M综合征

Femi Williams Adeoye1, Nida Jaffar2, Sanggeeta Surandran3

  • 1Southend University Hospital, Southend-on-Sea, United Kingdom.

European journal of case reports in internal medicine
|August 12, 2024
PubMed
概括

本案例研究突出了一个罕见的三重M综合征病例,这可能是免疫疗法,特别是杜尔瓦卢马布 (durvalumab) 的危及生命的副作用. 早期识别和多学科护理对于管理这种复杂的免疫相关不良事件至关重要.

关键词:
在 Durvalumab 中使用.我的第一个生日.肌性心肌炎是一种心肌炎.肌肉性肌肉性炎症 肌肉性肌肉炎三重M综合征是什么意思

更多相关视频

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

18.0K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.2K

相关概念视频

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
156